IP Library Assignment 074312/0259
Patent Assignment
Reel/Frame 074312/0259

Nunc Pro Tunc Assignment

Recorded: 2026-04-08 Pages: 4
Assignor
JAPAN TOBACCO INC.
Executed: 2026-03-26
Assignee
SHIONOGI & CO., LTD.
1-8, DOSHOMACHI 3-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 5410045, JAPAN
Covered Properties (32)
Indole Compounds and Pharmaceutical Use Thereof
Patent: 8,299,070 →
Application: 12/954,438 →
Publication: US 2011/0306599
Amide Compound and Medicinal Use Thereof
Patent: 8,604,069 →
Application: 13/457,844 →
Publication: US 2012/0322837
Pyrazole Compound and Pharmaceutical Use Thereof
Patent: 8,846,746 →
Application: 13/599,665 →
Publication: US 2013/0085132
Iron (Iii) Citrate, Substantially Free of Beta-Iron Hydroxide Oxide
Patent: 9,624,155 →
Application: 14/184,062 →
Publication: US 2015/0025138
Pyrazole-Amide Compounds and Pharmaceutical Use Thereof
Patent: 9,040,717 →
Application: 14/210,746 →
Publication: US 2014/0296315
Dihydropyrimidin-2-One Compounds and Medical Use Thereof
Application: 14/966,120 →
Publication: US 2016/0194290
Nitrogen-Containing Heteroaryl Compound and Pharmaceutical Use Thereof
Application: 16/150,989 →
Publication: US 2019/0152926
Nitrogen-Containing Heterocyclic Amide Compound and Pharmaceutical Use Thereof
Application: 16/261,792 →
Publication: US 2020/0017505
4-Methyldihydropyrimidinone Compounds and Pharmaceutical Use Thereof
Application: 16/287,870 →
Publication: US 2019/0300488
Therapeutic or Preventing Agent for Nephrotic Syndrome Including Indole Compound
Application: 17/056,931 →
Publication: US 2021/0236502
Method of Treating Pain or Interstitial Cystitis Using Indole Compound
Application: 17/056,936 →
Publication: US 2021/0205320
Therapeutic or Preventing Agent for Multiple Sclerosis Including Indole Compound
Application: 17/056,947 →
Publication: US 2021/0236503
4-Oxoquinoline Compound and Use Thereof as Pharmaceutical Agent
Patent: 7,176,220 →
Application: 10/492,833 →
Publication: US 2005/0239819
Combination Therapy
Patent: 8,633,219 →
Application: 11/133,463 →
Publication: US 2005/0288326
Stable Crystal of 4-Oxoquinoline Compound
Patent: 7,635,704 →
Application: 11/133,471 →
Publication: US 2006/0030710
Pyrimidine Compound and Medical Use Thereof
Patent: 7,378,423 →
Application: 11/150,792 →
Publication: US 2006/0014768
4-Oxoquinoline Compound and Use Thereof as Hiv Integrase Inhibitor
Patent: 8,232,401 →
Application: 11/446,128 →
Publication: US 2006/0217413
Method for Producing 4-Oxoquinoline Compound
Patent: 8,383,819 →
Application: 12/281,889 →
Publication: US 2009/0036684
Process for Production of 4-Oxoquinoline Compound
Patent: 8,420,821 →
Application: 12/281,921 →
Publication: US 2009/0318702
Stable Crystal of 4-Oxoquinoline Compound
Patent: 8,981,103 →
Application: 12/538,694 →
Publication: US 2010/0204271
Triazolopyridine Compound, and Action Thereof as Prolyl Hydroxylase Inhibitor or Erythropoietin Production-Inducing Agent
Patent: 8,283,465 →
Application: 12/837,679 →
Publication: US 2011/0077267
Nitrogen-Containing Spirocyclic Compounds and Pharmaceutical Uses Thereof
Patent: 8,609,647 →
Application: 12/847,025 →
Publication: US 2011/0136778
Method for Producing 7H-Pyrrolo[2, 3-D]Pyrimidine Derivative and Intermediate Thereof
Application: 15/741,926 →
Publication: US 2019/0062346
Methyllactam Ring Compound and Pharmaceutical Use Thereof
Application: 16/289,500 →
Publication: US 2019/0352284
Pyrazole Compounds Substituted with Heteroaryl and Pharmaceutical Use Thereof
Application: 16/374,460 →
Publication: US 2019/0330193
Method for Producing Triazolopyridine Compound
Application: 16/463,216 →
Publication: US 2020/0339563
Crystalline Forms of a Janus Kinase Inhibitor
Application: 16/470,854 →
Publication: US 2020/0017527
Process for Preparing 7H-Pyrrolo[2,3-D]Pyrimidine Derivatives and Co-Crystals Thereof
Application: 16/470,843 →
Publication: US 2020/0165269
Saturated-Ring-Fused Dihydropyrimidinone or Dihydrotriazinone Compounds and Pharmaceutical Use Thereof
Application: 17/334,517 →
Publication: US 2022/0119355
Tetrahydrobenzofurodiazepinone Compound and Pharmaceutical Use Thereof
Application: 17/493,528 →
Publication: US 2022/0162220
Triazine Compounds and Pharmaceutical Use Thereof
Application: 17/575,931 →
Publication: US 2023/0011968
Hydroxytriazine Compounds and Pharmaceutical Use Thereof
Application: 18/114,043 →
Publication: US 2024/0076278
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 15, 2004
From: SATOH, MOTOHIDE; KAWAKAMI, HIROSHI; ITOH, YOSHIHARU; MOTOMURA, TAKAHISA
To: JAPAN TOBACCO INC.
Reel/Frame 015887/0891 →
Assignment of Assignor's Interest Aug 29, 2005
From: MATSUZAKI, YUJI; WATANABE, WATARU; IKEDA, SATORU; KANO, MITSUKI
To: JAPAN TOBACCO INC.
Reel/Frame 016677/0731 →
Assignment of Assignor's Interest Sep 23, 2005
From: KAWASAKI, HISASHI; ABE, HIROYUKI; HAYAKAWA, KAZUHIDE; IIDA, TETSUYA
To: JAPAN TOBACCO INC.
Reel/Frame 016575/0646 →
Assignment of Assignor's Interest Oct 26, 2005
From: SATOH, MOTOHIDE; MOTOMURA, TAKAHISA; MATSUDA, TAKASHI; KONDO, KENTARO
To: JAPAN TOBACCO INC.
Reel/Frame 016942/0815 →
Corrective Coversheet to Correct the Spelling of T Jun 5, 2006
From: SATOH, MOTOHIDE; KAWAKAMI, HIROSHI; ITOH, YOSHIHARU; SHINKAI, HISASHI
To: JAPAN TOBACCO INC.
Reel/Frame 017736/0867 →
Assignment of Assignor's Interest Aug 23, 2011
From: INOUE, TERUHIKO; KAYA, TETSUDO; KIKUCHI, SHINICHI; MATSUMURA, KOJI
To: JAPAN TOBACCO INC.
Reel/Frame 026793/0685 →
Assignment of Assignor's Interest Aug 14, 2012
From: MAEBA, TAKAKI; MAEDA, KATSUYA; KOTOKU, MASAYUKI; HIRATA, KAZUYUKI
To: JAPAN TOBACCO INC.
Reel/Frame 028786/0052 →
Assignment of Assignor's Interest Apr 3, 2014
From: MIURA, TOMOYA; OGOSHI, YOSUKE; UEYAMA, KAZUHITO; MOTODA, DAI
To: JAPAN TOBACCO INC.
Reel/Frame 032596/0259 →
Assignment of Assignor's Interest Jun 18, 2014
From: MOTOMURA, TAKAHISA; SHOMI, GAKUJUN
To: JAPAN TOBACCO INC.
Reel/Frame 033124/0531 →
Assignment of Assignor's Interest Feb 29, 2016
From: YOKOTA, MASAHIRO; IKENOGAMI, TAKU; WATANABE, EIICHI; SEKI, NORIYOSHI
To: JAPAN TOBACCO INC.
Reel/Frame 037851/0333 →
Assignment of Assignor's Interest Dec 6, 2016
From: ANDO, KOJI; MANTA, NAOKI
To: JAPAN TOBACCO INC.
Reel/Frame 040535/0390 →
Assignment of Assignor's Interest Feb 7, 2019
From: NAGAMORI, HIRONOBU; NISHIMARU, TATSUYA; TAKAGI, MASAKI; MITANI, IKUO
To: JAPAN TOBACCO INC.
Reel/Frame 048266/0012 →
Assignment of Assignor's Interest May 17, 2019
From: SAKAI, TAKAYUKI; IKENOGAMI, TAKU
To: JAPAN TOBACCO INC.
Reel/Frame 049216/0448 →
Assignment of Assignor's Interest May 23, 2019
From: MAEBA, TAKAKI; SUZAWA, KOICHI; KOTOKU, MASAYUKI; MASUO, RITSUKI
To: JAPAN TOBACCO INC.
Reel/Frame 049271/0634 →
Security Interest Apr 2, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 052295/0662 →
Second Amended and Restated Intellectual Property Security Agreement Sep 2, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 053671/0221 →
Third Amended and Restated Intellectual Property Security Agreement Sep 10, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 054173/0451 →
Fourth Amended and Restated Intellectual Property Security Agreement Dec 17, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 054793/0455 →
Fifth Amended and Restated Intellectual Property Security Agreement Mar 30, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 055776/0491 →
Change of Address Apr 7, 2021
From: JAPAN TOBACCO INC.
To: JAPAN TOBACCO INC.
Reel/Frame 055859/0962 →
Change of Address Apr 9, 2021
From: JAPAN TOBACCO INC.
To: JAPAN TOBACCO INC.
Reel/Frame 056797/0633 →
Sixth Amended and Restated Intellectual Property Security Agreement Jun 11, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 056544/0468 →
Seventh Amended and Restated Intellectual Property Security Agreement Sep 12, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 057474/0770 →
Security Interest Dec 15, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 058399/0055 →
Assignee Change of Address Dec 27, 2021
From: JAPAN TOBACCO INC.
To: JAPAN TOBACCO INC.
Reel/Frame 058593/0913 →